A06.89 Other amebic infections

Name of the Condition

• Other amebic infections (ICD-10-CM Code: A06.89)

Summary

Other amebic infections represent extraintestinal manifestations of Entamoeba histolytica infection affecting sites not classified under more specific codes. These infections result from the parasite invading tissues outside the intestines, such as the skin, bones, or other organs, leading to localized inflammation and potential tissue damage. The condition arises from the spread of the parasite beyond the gastrointestinal tract, typically via the bloodstream or direct extension.

Causes

Other amebic infections are caused by the protozoan parasite Entamoeba histolytica. The parasite spreads to non-intestinal sites from the intestines, often through the bloodstream or direct extension. Transmission occurs through ingestion of cysts, commonly from contaminated food or water, which invade the intestinal lining and may disseminate to distant sites like the skin, bones, or other organs.

Risk Factors

• Living in or traveling to regions with poor sanitation.
• Consuming contaminated food or water.
• Weakened immune system, which may increase susceptibility to severe disease.
• Close contact with an infected individual or exposure to fecal matter.

Symptoms

• Site-specific symptoms depending on the affected organ (e.g., skin lesions, bone pain, or organ-specific dysfunction).
• Fever and systemic signs of infection.
• Localized pain, swelling, or discharge at the infection site.
• In severe cases, signs of organ failure or systemic illness.

Diagnosis

Diagnosis involves clinical evaluation of symptoms, identification of the infection site, and laboratory testing. Stool samples or tissue biopsies may be analyzed to detect E. histolytica cysts or trophozoites. Imaging studies (e.g., X-rays, CT scans) can help identify affected tissues. Serological tests or PCR may confirm the presence of the parasite in non-intestinal sites.

Treatment Options

Treatment typically includes antiparasitic medications such as metronidazole or tinidazole, followed by a luminal agent like paromomycin to eliminate intestinal cysts. Supportive care, including pain management or treatment of secondary infections, may be necessary depending on the infection site. Duration and specific regimens are tailored to the severity and location of the infection.

Prognosis and Follow-Up

Prognosis varies based on the infection site and timeliness of treatment. Early intervention generally leads to favorable outcomes, while delayed treatment may result in complications. Follow-up may include monitoring for recurrence, repeat testing to confirm parasite clearance, and evaluation of organ function if affected.

Complications

• Tissue damage or scarring at the infection site.
• Spread to other organs if untreated.
• Secondary bacterial infections.
• Chronic inflammation or persistent symptoms in severe cases.

Lifestyle & Prevention

• Avoid consuming untreated water or food in regions with poor sanitation.
• Practice good hygiene, including handwashing after using the restroom or handling food.
• Cook food thoroughly and avoid raw or undercooked items in high-risk areas.
• Seek medical care promptly if symptoms of infection develop after travel.

When to Seek Professional Help

Consult a healthcare provider if you experience unexplained fever, localized pain, or symptoms of infection after potential exposure to contaminated sources. Seek immediate care for severe symptoms, such as organ dysfunction or systemic illness.

Tips for Medical Coders

Document the specific site of infection (e.g., skin, bone) to support the use of A06.89. Include clinical details confirming extraintestinal amebiasis and exclude more specific codes when applicable. Ensure documentation aligns with the infection site and supports the diagnosis for accurate coding.